Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 May;35(5):541–543. doi: 10.1136/jcp.35.5.541

Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies?

P R Mills, P Boyle, E M Quigley, G G Birnie, F Jarrett, G Watkinson, R N MacSween
PMCID: PMC497712  PMID: 7085897

Abstract

In a retrospective review of 85 patients with primary biliary cirrhosis (PBC), 10 (11.8%) were noted to have extrahepatic malignant neoplasm. In seven female patients the tumour developed within a mean of 3.5 yr after the clinical onset of PBC. This observed number of tumours, 3.5 times more common than the expected age-adjusted incidence, was statistically significant at the 0.5% level.

Full text

PDF
541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaput J. C., Buffet C., Papoz L., Etienne J. Chronic active hepatitis and extrahepatic malignancy. Lancet. 1978 Jun 24;1(8078):1367–1367. doi: 10.1016/s0140-6736(78)92449-2. [DOI] [PubMed] [Google Scholar]
  2. Crowe J., Christensen E., Smith M., Cochrane M., Ranek L., Watkinson G., Doniach D., Popper H., Tygstrup N., Williams R. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology. 1980 May;78(5 Pt 1):1005–1010. [PubMed] [Google Scholar]
  3. Hill I. D. Computing man years at risk. Br J Prev Soc Med. 1972 May;26(2):132–134. doi: 10.1136/jech.26.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kinlen L. J., Eastwood J. B., Kerr D. N., Moorhead J. F., Oliver D. O., Robinson B. H., de Wardener H. E., Wing A. J. Cancer in patients receiving dialysis. Br Med J. 1980 Jun 14;280(6229):1401–1403. doi: 10.1136/bmj.280.6229.1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Krasner N., Johnson P. J., Portmann B., Watkinson G., Macsween R. N., Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut. 1979 Mar;20(3):255–258. doi: 10.1136/gut.20.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MacSween R. N., Scott A. R. Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol. 1973 Dec;26(12):936–942. doi: 10.1136/jcp.26.12.936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Miller D. G. The association of immune disease and malignant lymphoma. Ann Intern Med. 1967 Mar;66(3):507–521. doi: 10.7326/0003-4819-66-3-507. [DOI] [PubMed] [Google Scholar]
  8. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery. 1978 May;83(5):492–502. [PubMed] [Google Scholar]
  9. Symington G. R., Mackay I. R., Lambert R. P. Cancer and teratogenesis: infrequent occurrence after medical use of immunosuppressive drugs. Aust N Z J Med. 1977 Aug;7(4):368–372. doi: 10.1111/j.1445-5994.1977.tb04397.x. [DOI] [PubMed] [Google Scholar]
  10. Viteri A., Vernace S. J., Schaffner F. Extrahepatic malignancy in chronic liver disease: report of six cases. Gastroenterology. 1976 Dec;71(6):1075–1078. [PubMed] [Google Scholar]
  11. Wald N., Idle M., Boreham J., Bailey A. Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet. 1980 Oct 18;2(8199):813–815. doi: 10.1016/s0140-6736(80)90169-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES